MYCOPHYTO was co-founded in 2017 by Justine LIPUMA, a doctor in microbiology, and Christine PONCET, an agricultural engineer. Spin off INRAE (INRA) and UCA (Université Côte d'Azur), it has received more than 12 awards since its creation.
MYCOPHYTO is to develop, produce and propose to agricultural professionals effective biological solutions by adapting scientific knowledge concerning mycorrhizal symbiosis.
MYCOPHYTO, an INRAE and UCA spin-off, integrates the latest knowledge from life sciences and technological innovations. The start-up has patented solutions for the implementation of native arbuscular mycorrhizal fungi (AMFs) in crops to recreate sustainable natural synergies with plant roots.
MYCOPHYTO is based on a dynamic of key players including: world-renowned scientists, joint research structures, technical and training institutes and farmer ambassadors.
The Bio-inspired Chemistry and Ecological Innovations laboratory, known as ChimEco, brings together researchers and engineers from the CNRS and a teacher-researcher from the University of Montpellier. As its activities are highly valued by industry, half of the researchers are financed by industrial contracts. The ChimEco laboratory is located in the Cap Delta business centre in the Montpellier agglomeration, in the heart of the Euromedicine park biopole.
The ambitions of the ChimEco laboratory are to develop an interdisciplinary approach to global ecology as a vector for sustainable development.
The unusual combination of phytotechnologies adapted to pollution, the ecological rehabilitation of degraded sites and the valorisation of these processes by an innovative and bio-inspired green chemistry, ecocatalysis, must contribute to the development of the current scientific, economic and environmental priorities of ecological innovation.
Claude Grison's speech at Biomim'expo 2017 :
The film Nature=Future:
TEDx 2015 :
Klorane Botanical Foundation - Mint, a plant that cleanses water:
Biocontrol is the set of methods for protecting crops against pathogens by using natural organisms and/or substances.
The story: two long-time friends, a researcher and an agronomist, committed and experienced, with complementary profiles, founded Immunrise Biocontrol, a French and independent company which emanates from the Institute of Biology of the Ecole Normale Supérieure (IBENS, Paris). Their objective is to identify and develop non-GMO solutions drawn from nature to ensure the protection of our crops. The principle is to identify marine micro-organisms capable of either stimulating the natural defences of plants or acting directly on pathogens, limiting the development of disease on plants. Immunrise Biocontrol will therefore make it possible to improve the yield and quality of cultivated plants while reducing the use of synthetic pesticides.
France 2 - Journal 13H le 28/01/2017
A young company in Bordeaux has discovered a microscopic algae that could be an alternative to pesticides. It is sometimes used in New Aquitaine in vineyards.
France 2 - 1pm news on 17/09/2017
Treating vines with algae instead of pesticides is the discovery of a young Bordeaux company. The first tests have proved conclusive.
ECOMNEWS - January 2017
Immunrise Biocontrol, based in Pessac, has discovered a micro-algae that produces molecules with promising bio-pesticidal properties. Interview with Laurent De Crasto, CEO of Immunrise and Alain Rousset, President of the Nouvelle-Aquitaine Region, during his visit to the start-up on 13 January.
Le Figaro A Bordeaux-based company discovers a promising bio-pesticide algae
Laurent de Crasto, co-founder of IMMUNRISE
Laurent de Crasto is an agricultural engineer specialising in viticulture and graduated from Sup Agro Montpellier. He worked at the Institut National de l'Origine et de la Qualité in Paris before co-founding two innovative industrial companies based in Bordeaux:
WIT France in 2007, specialised in small volume wine packaging (15 employees, €2m turnover in 2016)
In 2011, he co-founded VDLV (90 employees, €8m turnover in 2018) which develops E-liquids based on natural flavours, a leading company on the French market.
In 2012, he became a member and treasurer of Innovin, the New Aquitaine cluster for wine innovation.
In 2015, he created with Lionel Navarro the company ImmunizationImmunrise, specialised in the research and development of biotechnological solutions. In 2016, Immunrise's biocontrol subsidiary was created in Pessac, in the Nouvelle-Aquitaine region of France, and focuses its research on marine microorganisms to treat plants.
Immunrise aims to develop innovative biocontrol solutions for crop protection. The conceptual approach initiated by its founders at the time of its creation is to identify marine microorganisms of agronomic interest. This simple and direct approach required long and tedious research and selection of microorganism strains, which were carried out by Dr Navarro's laboratory, of which Immunrise is the spin-off.
We create new microfluidic solutions that revolutionise industry.
From microfabrication kits to biomimetic high-yield systems.
Our goal is to develop solutions to boost microfluidics R&D and to translate these technologies into products. Whether by providing support to individual innovators, institutions, or at the industrial scale.
Eden Tech (fomerly Eden Microfluidics) was created in 2017 to explore the untapped potential of microfluidics. We began our focus on the design and commercialization of a novel material, which then led to the creation of supporting services for simulation, prototyping, and mass production. Our high performance products enable affordable, rapid, high-quality and high throughput production of chips. This is the heart of our Eden Materials and Eden Lab divisions.
More recently, our efforts have also turned to microfluidics design and engineering solutions to tackle global challenges. We are developing biomimetic systems for 2 key applications: Water Treatment & Artificial Organs. Our designs are particularly well adapted for high-volume microfluidics, processing in the scale of 100 000 liters per day or more. Inspired by nature, massive microfluidic integration will now have the opportunity to revolutionise the industrial landscape. Much like microelectronics did 50 years ago. For more information on these activities head to our Eden Cleantech and Eden Medtech divisions.
At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That's why for more than 130 years, we have aimed to keep people well at every age and every stage of life. Today, as the world's largest and most broadly based healthcare company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere.
Every day, our more than 130,000 employees across the world are blending heart, science and ingenuity to profoundly change the trajectory of health for humanity.
Aspiring Toward a Healthier World
We aspire to improve health in all we do and everywhere we go. Citizenship and sustainability have long been engrained in our culture, built on a foundational belief that a healthier planet offers benefits to human health.To ensure we live up to our commitments, we have a long legacy of goal setting, having established the first public goals in 1990. Our newly named Johnson & Johnson Health for Humanity 2020 Goals expanded how we think about health and we have sought out new ways to make everyone, everywhere, healthier.
We ensure people have access to better care around the world, make the places we live, work and play healthier by using fewer resources, and team up with partners and employees to further advance our culture of health and well-being.
"We produce biodegradable sugars and plastics points out Anthony Courtois, President of Polymaris, who stresses that "marine biodiversity is greater than that of the terrestrial ecosystem . The leader believes that the company has "Generating a collection of microorganisms suitable for future industrial use . And there's plenty to do: the markets are varied, from cosmetics to medical devices to phytosanitary products. The startup, which was born in the Ifremer laboratories in Brest where its co-founders did their doctorate, says it did not need to raise funds to finance itself because it is making "of the turnover since the beginning of its activity".. However, the sector's own funding issues also resonate with her. "We could use financial partners to outsource certain activities. says Anthony Courtois, according to whom he "We need to trust small structures more"..
Annette ESNAULT-FILET is the Biocalcis Development Manager in the Technical Department of Soletanche Bachy International.
On 20 October at Biomim'expo, she will present the development of the Biocalcis process for soil reinforcement by biocalcification, describing the main R&D stages that led to the industrial process as it exists today.
ARCANE Laboratory of Excellence (Labex): a motivated bio-chemistry
Taking from Nature to give back to Nature
Chemistry now faces two fundamental challenges: designing its future without fossil fuels and integrating current knowledge of molecular biology to design new and more efficient bio-molecular systems. The considerable progress made recently in the field of structural biology has indeed opened up new perspectives and inspired chemists.
The core of ARCANE is the design, synthesis and application of new bio-inspired or bio-targeted molecular architectures in the context of translational research on 3 topics related to the maintenance and progress of human society: energy, environment and health. The ARCANE partners are working towards a common scientific objective: biomotivated chemistry, from bioinspiration to biotargeted molecules.
This objective is based on a shared scientific vision and complementary know-how. It is based on two "vertical" scientific axes: Bio-inspired Chemistry and Bio-targeted Chemistry, which is based on an Emergence foundation.
The ARCANE Labex brings together seven partners from complementary fields to develop these future-oriented research themes.
At ENGIE, we are convinced that the development of renewable energies and infrastructures will only be possible if the environment is respected. This natural capital, just like our human, financial, material or immaterial capital, is therefore just as important in preserving our capacity for action and maintaining our sustainability.
Biomimicry is thus one of the keys to our strategy. With it, we show our desire to better understand and involve living things in our thinking in order to bring out solutions that are not only sustainable, but also regenerative, to create the conditions for a desirable future for all.
This year again, we are supporting the Biomim'Challenge, a competition open to all projects that have one thing in common: integrating the biomimetic approach into their discipline (architecture, design, materials, agriculture, chemistry, energy, health, human resources, city, etc.).
This partnership with Biomim'Expo and the Biomim'Challenge gives resonance and meaning to our raison d'être.
Some examples of research projects and achievements in the field of biomimicry at ENGIE:
Climate change and the depletion of natural resources are inviting us every day to rethink our relationship with nature. Biomimicry is a resource that we are investing in very seriously to respond to this environmental emergency and meet the needs of our businesses.
Bioscyance: a project to use biopolymers in the treatment of industrial and urban water
Ecotone is an 82,000 m² real estate project developed on the Arcueil site. Winner of the "Inventons la Métropole du Grand Paris" competition, Ecotone places biomimicry at the heart of the building's architectural structure by creating a living skin. The walls function like a double skin: they adapt to temperature variations and optimise the building's energy consumption. The Compagnie de Phalsbourg, the project owner, and ENGIE Lab Crigen are including Ecotone in a low-carbon approach, in particular by facilitating the recovery of hot waste water, the installation of solar panels and the installation of urban wind turbines. https://www.engie.com/innovation-transition-energetique/centres-de-recherche/crigen/
Wind turbines: acoustic innovation and biomimicry
Vigilant about the real impacts after construction of wind farms and the feelings of local residents during operation, ENGIE Green has developed an acoustic innovation inspired by nature, which consists of fitting the blades of wind turbines with "serrations" that imitate the wings of an owl. This nocturnal bird of prey, which hunts by hearing, seeks silent flight. This technology has resulted in a significant reduction in noise without affecting the production of the wind farm. https://projet-eolien-quillien.fr/innovation-acoustique-et-biomimetisme/
A podcast to rethink our relationship with nature
At a time when our lifestyle and consumption patterns are endangering the environment, it is time to look again to nature as a source of inspiration and innovation, thanks to biomimicry. What lessons can we learn from the functioning of living organisms? How can we reproduce natural structures in materials? How can we reintegrate the water cycle into our urban ecosystems? And above all, how can we place biomimicry at the heart of R&D strategies? https://shows.pippa.io/the-good-galaxy/episodes/repenser-notre-rapport-a-la-nature
Our raison d'être is to act to accelerate the transition to a carbon-neutral economy, through more energy-efficient and environmentally friendly solutions. This raison d'être brings us together with our 170,000 employees, our customers and our shareholders and reconciles economic performance with a positive impact on people and the planet. Our action is to be appreciated in its entirety and over the long term.
Turnover in 2019: €60 billion. Listed in Paris and Brussels (ENGI), the Group is represented in the main financial (CAC 40, DJ Euro Stoxx 50, Euronext 100, FTSE Eurotop 100, MSCI Europe) and extra-financial (DJSI World, DJSI Europe and Euronext Vigeo Eiris - World 120, Eurozone 120, Europe 120, France 20, CAC 40 Governance) indices.